Takeda Pharmaceutical £46 billion acquisition of Shire

10/5/2018
Public acquisition

£ 46 billion

$ 62.041 billion

Announced

10/5/2018


Overview:

  • Takeda Pharmaceutical is set to takeover LSE listed Shire in a £46 billion deal.
  • Shareholders in Shire, an Irish pharma company, will receive $30.33 per share under the agreed deal.
  • The acquisition will see Takeda become the leading Japan-based global biopharmaceutical company.

Rajeeb Gurung - Researcher

Continue reading...

New to IFLR1000?

Register today for FREE:

  • Understand market dynamics, with data broken by deal type and more
  • Access law firms and lawyers involved in deals
  • Gain unique insight into lawyers recent work
REGISTER NOW

Sign in